Literature DB >> 24217707

Prevalence and classification of chronic kidney disease in cats randomly selected from four age groups and in cats recruited for degenerative joint disease studies.

Christina L Marino1, B Duncan X Lascelles2, Shelly L Vaden3, Margaret E Gruen4, Steven L Marks5.   

Abstract

Chronic kidney disease (CKD) and degenerative joint disease are both considered common in older cats. Information on the co-prevalence of these two diseases is lacking. This retrospective study was designed to determine the prevalence of CKD in two cohorts of cats: cats randomly selected from four evenly distributed age groups (RS group) and cats recruited for degenerative joint disease studies (DJD group), and to evaluate the concurrence of CKD and DJD in these cohorts. The RS group was randomly selected from four age groups from 6 months to 20 years, and the DJD group comprised cats recruited to four previous DJD studies, with the DJD group excluding cats with a blood urea nitrogen and/or serum creatinine concentration >20% (the upper end of normal) for two studies and cats with CKD stages 3 and 4 for the other two studies. The prevalence of CKD in the RS and DJD groups was higher than expected at 50% and 68.8%, respectively. CKD was common in cats between 1 and 15 years of age, with a similar prevalence of CKD stages 1 and 2 across age groups in both the RS and DJD cats, respectively. We found significant concurrence between CKD and DJD in cats of all ages, indicating the need for increased screening for CKD when selecting DJD treatments. Additionally, this study offers the idea of a relationship and causal commonality between CKD and DJD owing to the striking concurrence across age groups and life stages. © ISFM and AAFP 2013.

Entities:  

Mesh:

Year:  2013        PMID: 24217707      PMCID: PMC4414065          DOI: 10.1177/1098612X13511446

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  27 in total

1.  Effect of reproductive status on feline renal size.

Authors:  J T Shiroma; J K Gabriel; R L Carter; S L Scruggs; P W Stubbs
Journal:  Vet Radiol Ultrasound       Date:  1999 May-Jun       Impact factor: 1.363

2.  Evaluation of client-specific outcome measures and activity monitoring to measure pain relief in cats with osteoarthritis.

Authors:  B Duncan X Lascelles; Bernie D Hansen; Simon Roe; Venita DePuy; Andrea Thomson; Courtney C Pierce; Eric S Smith; Elizabeth Rowinski
Journal:  J Vet Intern Med       Date:  2007 May-Jun       Impact factor: 3.333

3.  Prevalence of radiographic signs of degenerative joint disease in a hospital population of cats.

Authors:  S P Clarke; D Mellor; D N Clements; T Gemmill; M Farrell; S Carmichael; D Bennett
Journal:  Vet Rec       Date:  2005-12-17       Impact factor: 2.695

4.  Radiographic evidence of degenerative joint disease in geriatric cats: 100 cases (1994-1997).

Authors:  Elizabeth M Hardie; Simon C Roe; Fonda R Martin
Journal:  J Am Vet Med Assoc       Date:  2002-03-01       Impact factor: 1.936

5.  Disposition of plasma creatinine in non-azotaemic and moderately azotaemic cats.

Authors:  Alain Le Garreres; Valérie Laroute; France De La Farge; Karine G Boudet; Hervé P Lefebvre
Journal:  J Feline Med Surg       Date:  2006-10-16       Impact factor: 2.015

6.  Naturally-occurring chronic renal disease in Australian cats: a prospective study of 184 cases.

Authors:  J D White; J M Norris; R M Baral; R Malik
Journal:  Aust Vet J       Date:  2006-06       Impact factor: 1.281

7.  Feline chronic renal failure: clinical findings in 80 cases diagnosed between 1992 and 1995.

Authors:  J Elliott; P J Barber
Journal:  J Small Anim Pract       Date:  1998-02       Impact factor: 1.522

Review 8.  Radiographic features of feline joint diseases.

Authors:  G S Allan
Journal:  Vet Clin North Am Small Anim Pract       Date:  2000-03       Impact factor: 2.093

9.  Health status and population characteristics of dogs and cats examined at private veterinary practices in the United States.

Authors:  E M Lund; P J Armstrong; C A Kirk; L M Kolar; J S Klausner
Journal:  J Am Vet Med Assoc       Date:  1999-05-01       Impact factor: 1.936

10.  Clinicopathologic findings associated with chronic renal disease in cats: 74 cases (1973-1984).

Authors:  S P DiBartola; H C Rutgers; P M Zack; M J Tarr
Journal:  J Am Vet Med Assoc       Date:  1987-05-01       Impact factor: 1.936

View more
  52 in total

1.  Preliminary study of urinary excretion of liver-type fatty acid-binding protein in a cat model of chronic kidney disease.

Authors:  Akiko Watanabe; Keiichi Ohata; Tsuyoshi Oikawa; Takeshi Sugaya; Masao Miyazaki; Hiroshi Satoh; Masaaki Katayama
Journal:  Can J Vet Res       Date:  2021-04       Impact factor: 1.310

2.  Evaluation of serum cytokines in cats with and without degenerative joint disease and associated pain.

Authors:  Margaret E Gruen; Kristen M Messenger; Andrea E Thomson; Emily H Griffith; Lauren A Aldrich; Shelly Vaden; B Duncan X Lascelles
Journal:  Vet Immunol Immunopathol       Date:  2016-12-16       Impact factor: 2.046

3.  The Multicomponent, Multitarget Therapy SUC in Cats with Chronic Kidney Disease: A Multicenter, Prospective, Observational, Nonrandomized Cohort Study.

Authors:  Uta Brandenburg; Gabriele Braun; Peter Klein; Erich Reinhart
Journal:  Complement Med Res       Date:  2020-03-26       Impact factor: 1.211

4.  Criterion Validation Testing of Clinical Metrology Instruments for Measuring Degenerative Joint Disease Associated Mobility Impairment in Cats.

Authors:  Margaret E Gruen; Emily H Griffith; Andrea E Thomson; Wendy Simpson; B Duncan X Lascelles
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

5.  Urinary active transforming growth factor β in feline chronic kidney disease.

Authors:  J S Lawson; H M Syme; C P D Wheeler-Jones; J Elliott
Journal:  Vet J       Date:  2016-02-12       Impact factor: 2.688

6.  Evaluation of Feline Renal Perfusion with Contrast-Enhanced Ultrasonography and Scintigraphy.

Authors:  Emmelie Stock; Katrien Vanderperren; Tim Bosmans; André Dobbeleir; Luc Duchateau; Myriam Hesta; Lien Lybaert; Kathelijne Peremans; Eva Vandermeulen; Jimmy Saunders
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

7.  Symmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus.

Authors:  R Langhorn; I N Kieler; J Koch; L B Christiansen; L R Jessen
Journal:  J Vet Intern Med       Date:  2017-12-12       Impact factor: 3.333

8.  Relationship between Plasma Fibroblast Growth Factor-23 Concentration and Survival Time in Cats with Chronic Kidney Disease.

Authors:  R F Geddes; J Elliott; H M Syme
Journal:  J Vet Intern Med       Date:  2015-09-25       Impact factor: 3.333

9.  A Feline-Specific Anti-Nerve Growth Factor Antibody Improves Mobility in Cats with Degenerative Joint Disease-Associated Pain: A Pilot Proof of Concept Study.

Authors:  M E Gruen; A E Thomson; E H Griffith; H Paradise; D P Gearing; B D X Lascelles
Journal:  J Vet Intern Med       Date:  2016-06-22       Impact factor: 3.333

10.  Evaluation of Cystatin C for the Detection of Chronic Kidney Disease in Cats.

Authors:  L F E Ghys; D Paepe; H P Lefebvre; B S Reynolds; S Croubels; E Meyer; J R Delanghe; S Daminet
Journal:  J Vet Intern Med       Date:  2016-07       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.